BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹153 Cr | ₹148 Cr | ₹130 Cr | ₹90 Cr | ₹86 Cr |
What is the latest Total Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹153 Cr |
| Mar2024 | ₹148 Cr |
| Mar2023 | ₹130 Cr |
| Mar2022 | ₹90 Cr |
| Mar2021 | ₹86 Cr |
How is Total Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹153 Cr | 3.65 | |
| Mar2024 | ₹148 Cr | 13.97 | |
| Mar2023 | ₹130 Cr | 43.75 | |
| Mar2022 | ₹90 Cr | 4.25 | |
| Mar2021 | ₹86 Cr | - | |
Compare Total Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹327.8 Cr | 0.2% | -2.7% | 84.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 0.2% |
-2.7% |
84.4% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses